• Info
  • Insider Ownership

Insider Trading & Ownership of Helen M. Thackray

Location
Gaithersburg, MD
Summary
The estimated net worth of Helen M. Thackray is at least $2,931,593 dollars as of 02 Apr 2025. Helen M. Thackray is the Chief R&D Officer of BIOCRYST PHARMACEUTICALS INC and owns shares of BIOCRYST PHARMACEUTICALS INC (BCRX) stock worth about $2.83M. Helen M. Thackray is the Director of ImmunoGen, Inc. and owns shares of ImmunoGen, Inc. stock worth about $101.7K.
Signature
/s/ Alane P. Barnes, by power of attorney
All Insider Reports
All Insider Reports

Notify me when Helen M. Thackray files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Helen M. Thackray

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BCRX BIOCRYST PHARMACEUTICALS INC Chief R&D Officer $2,829,885 31 Mar 2025
IMGN ImmunoGen, Inc. Director $101,708 12 Feb 2024

Insider Transactions Reported by Helen M. Thackray:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.